Search | SocialyTime

Shweta Kadam added blog Other
2026-01-30 05:31:02 -

HER2 Positive Breast Cancer Treatment Market: Advancing Precision Oncology Through Targeted Therapies
Market Introduction HER2 positive breast cancer represents a biologically distinct and clinically aggressive subtype of breast cancer characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein. This overexpression accelerates tumor growth and increases the likelihood of disease progression if left untreated. Over the past two decades, advancements in...

0 Comments 0 Shares 665 Views 0 Reviews

Please log in to like, share and comment!
Aryan Mhatre added blog Art
2026-01-05 12:53:01 -

Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights
"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...

0 Comments 0 Shares 4K Views 0 Reviews

Please log in to like, share and comment!
Komal Galande added blog Art
2026-04-06 04:48:01 -

Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?
Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...

0 Comments 0 Shares 508 Views 0 Reviews

Please log in to like, share and comment!
Komal Galande added blog Drinks
2026-04-06 08:04:55 -

Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?
Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...

0 Comments 0 Shares 609 Views 0 Reviews

Please log in to like, share and comment!